#trontinemab
Trontinemab
Monoclonal antibody
Trontinemab (RG6102) is a monoclonal antibody developed by Roche/Genentech for the treatment of Alzheimer's disease. It is based on gantenerumab, an anti-amyloid monoclonal antibody, and using a Brainshuttle domain for transfer through the blood-brain barrier. Compared to gantenerumab, it has 50 times as much penetrance into the brain.
Mon 26th
Provided by Wikipedia
This keyword could refer to multiple things. Here are some suggestions:
0 searches
This keyword has never been searched before
This keyword has never been searched for with any other keyword.